Sign In
NewsRadar

Search Press
Looking for press releases of a particular company? Enter company name (or keyword) here.

   


Imperial Innovations invests in ATT
Investment in Advanced Tissue Therapies Ltd


31st January 2007 -- Imperial Innovations Group plc (AIM: IVO), the technology commercialisation and investment company, today announces that it is investing £469,000 in Advanced Tissue Therapies Limited (”ATT”), a biomaterials company that develops tissue engineering products aimed at orthopaedic and maxillofacial markets. The investment in ATT is part of a £769,000 seed funding round that also includes a £50,000 investment from Mr. Mark Rowan. Mr Rowan, who is a Non-executive Director of Imperial Innovations Group plc, will also become a Non–executive Director of ATT.

ATT will use the investment to develop two generations of products that promise better clinical outcomes for patients than current treatments. The first is a series of bioactive glasses with innovative features designed to promote bone growth that have been developed by Dr Molly Stevens and Professor Robert Hill of the Department of Materials at Imperial College London. The second is a family of materials designed to help the body repair soft tissues as well as bone.

Susan Searle, CEO, Imperial Innovations, said, “Advanced Tissue Therapies is a company built upon both strong research and real entrepreneurial drive. We look forward to supporting them as they develop and market their products, for which we would anticipate strong demand in established markets.”

Daniel Green, CEO, ATT, said, “The quality of our technology gives us a firm foundation, beyond that of most start-ups. We are delighted that our investors have demonstrated their confidence in our ability to develop it for the benefit of patients.”


About Imperial Innovations
Imperial Innovations is one of the UK's leading technology transfer and commercialisation companies. The company was founded in 1986 and its ordinary shares admitted to trading on the AIM Market of London Stock Exchange plc in July 2006, raising £26 million. The company’s integrated approach encompasses the identification of ideas, protection of intellectual property, development and licensing of technology and formation, incubation and investment in technology businesses. A wide range of technologies are commercialised within the areas of healthcare, energy, environment and emerging technology trends.

Based at Imperial College London, the company has established equity holdings in 66 technology businesses and has completed 90 commercial agreements. Imperial Innovations also commercialises technologies originating from outside Imperial College through incubation contracts with the Carbon Trust and WRAP and has relationships with a number of multinational corporations including BAE Systems.

Imperial Innovations has invested in a range of spin-out companies, including The Acrobot Company Limited, Cardiak Limited, deltaDOT Limited, Future Waves PTE Limited, HeliSwirl Technologies Limited, InforSense Limited, Lontra Limited, Midaz Lasers Limited, NanoBioDesign Limited, Nexeon Limited, NovaThera Limited, Thiakis Limited and Veryan Medical Limited.

Imperial Innovations currently holds shares in four technology businesses now listed on AIM including the fuel cell company, Ceres Power plc.


About ATT
Advanced Tissue Therapies Limited is a biomaterials company with proprietary technologies for the development of tissue engineering products aimed initially at orthopaedic and maxillofacial markets.
xx


Publisher Contact Information:

Imperial College Innovations Limited
+44 (0)20 7594 6591
-

Company profile of Touchstone Innovations (formerly Imperial Innovations)
Past press releases of Touchstone Innovations (formerly Imperial Innovations).

Data


26,673
Tech investments
From our Online Data Service
17,217
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Nov 25€24.0MInternet commerce
Feb 14€19.0MBiopharmaceuticals
Feb 14N/AInternet services
Feb 14€4.6MBusiness applications
Feb 13€13.0MBiopharmaceuticals
Feb 13€25.0MMedical devices
Feb 13€15.0MBusiness applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


May 28
Identiq
identiq raises $5m seed, launches privacy-first identity validation...

Apr 29
Nethone
nethone raised over $1 million from innovation nest

Jan 29
Yumpingo
yumpingo raises $10m to transform guest experiences in restaurants

Oct 1
The Link App
the link app launches version 2.0

Mar 29
Addex Therapeutics
addex sucessfully raises chf40 million in capital increase





About usContact usLegal Information
Copyright © 1999-2019
Emerging Technology Research Europe Inc. All rights reserved.